New Class of Meds for Heart Failure — We Were Part of the Trials
My wife was part of the medical experiments, and it was a success!
The American Heart Association, the Heart Failure Society of America, and the American College of Cardiology released some new guidelines, on April 1st.
In the new guidelines, a set of drugs is being recommended for patients experiencing heart failure that work differently from those previously approved.
The most interesting part of this for my family is the fact my wife was a part of the trials to get this approval.
A little backstory to catch you up.
My wife’s 32 now, and was born with a Congenital Heart Defect (CHD) called Tricuspid Atresia.
This defect causes one chamber of the heart (the lower right, in her case) to either not form at all during gestation, or deform.
In order to save her life, the doctors performed a special surgery called a Fontan shunt procedure. In that surgery, a shunt, or small tube, is placed within the heart to allow the flow of blood between the heart and lungs, which would have issues if it were not there.
She had that surgery when she was four, though she had a couple of others before then to…
